The value of sex hormones and sex hormone-binding globulin in metabolic dysfunction-associated fatty liver disease among boys with obesity

The value of sex hormones and sex hormone-binding globulin in metabolic dysfunction-associated fatty liver disease among boys with obesity

ObjectiveThis study aims to investigate the relationship between metabolic dysfunction-associated fatty liver disease (MAFLD) and sex hormones and sex hormone-binding globulin (SHBG) in boys with obesity.MethodsRetrospective analysis of metabolic indicators and sex hormone levels in boys with obesit...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ying Wang, Shuyi Yang, Suming Zhang, Ye Yang, Siqing Li, Meiyu Zhang, Xiaona Li, Hua Bai, Peiliang Luo, Yingdi Yuan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Endocrinology
Subjects:	childhood obesity metabolic dysfunction-associated fatty liver disease (MAFLD) non-alcoholic fatty liver disease (NAFLD) sex hormone-binding globulin (SHBG) testosterone
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1446049/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of sex hormone-binding globulin and dyslipidemia with Japanese postmenopausal women: a cross-sectional study
by: Takahiro Ichikawa, et al.
Published: (2025-06-01)

A Scientometric Assessment of MAFLD in Children and Adolescents from 2007–2024
by: Raju Vaishya, et al.
Published: (2025-07-01)

The Management of Cardiometabolic Risk in MAFLD: Therapeutic Strategies to Modulate Deranged Metabolism and Cholesterol Levels
by: Annalisa Pezzoli, et al.
Published: (2025-02-01)

Sex-specific associations of sex hormone binding globulin and risk of bladder cancer
by: Ou Junyong, et al.
Published: (2025-02-01)

Sex hormone-binding globulin as a biomarker for metabolic risk in European women with polycystic ovary syndrome
by: Bo E. van Bree, et al.
Published: (2025-12-01)

New steatotic liver disease criteria diagnostic performance in an agricultural population in Chile
by: Maria Spencer-Sandino, et al.
Published: (2025-07-01)

Genetic correlations of alcohol consumption and alcohol use disorder with sex hormone levels in females and males
by: T. Cameron Waller, et al.
Published: (2025-07-01)

New Insights in the Diagnostic Potential of Sex Hormone-Binding Globulin (SHBG)—Clinical Approach
by: Weronika Szybiak-Skora, et al.
Published: (2025-05-01)

The effects of kefir drink on liver aminotransferases and metabolic indicators in patients with nonalcoholic fatty liver disease: a randomized controlled trial
by: Farzaneh Mohammadi, et al.
Published: (2025-01-01)

Sex hormone imbalance and rheumatoid arthritis in American men: a cross-sectional analysis from NHANES 2011–2016
by: Pengfei Wen, et al.
Published: (2024-12-01)

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategy
by: Siwen Shen, et al.
Published: (2025-07-01)

Sex hormone-binding globulin promotes the osteogenic differentiation potential of equine adipose-derived stromal cells by activating the BMP signaling pathway
by: Jennifer M. Irwin-Huston, et al.
Published: (2024-10-01)

Diagnostic accuracy of Fatty Liver Index (FLI) for detecting Metabolic Associated Fatty Liver Disease (MAFLD) in adults attending a tertiary care hospital, a cross-sectional study
by: Roshni Vamja, et al.
Published: (2024-12-01)

Sex hormone-binding globulin controls sex-specific lipolytic activity in human abdominal subcutaneous adipocytes
by: Julie Abildgaard, et al.
Published: (2025-08-01)

Features and relationships of metabolic syndrome components in men with androgen deficiency. Part 1. Are body composition parameters, sex hormone levels and blood pressure interrelated?
by: Z. Sh. Pavlova, et al.
Published: (2021-11-01)

Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis
by: Farah Abdelhameed, et al.
Published: (2025-04-01)

Metabolic Syndrome in Adults with Nonalcoholic Fatty Liver Disease
by: Zhahid Hassan, et al.
Published: (2021-09-01)

Maternal gestational hypertension, smoking and pre‐eclampsia are associated with metabolic dysfunction‐associated fatty liver disease in overweight offspring
by: Hanna deRuyter, et al.
Published: (2024-06-01)

Cth/Mpst double ablation results in early onset fatty liver disease in lean mice
by: Antonia Katsouda, et al.
Published: (2025-06-01)

Hepatic HSD17B6 is dispensable for diet-induced fatty liver disease in mice
by: Delong Yuan, et al.
Published: (2025-03-01)

Prevalence of metabolic dysfunction-associated fatty liver disease among information technology employees in India
by: Bharam Bhargava, et al.
Published: (2025-03-01)

Genetic Variants Linked with the Concentration of Sex Hormone-Binding Globulin Correlate with Uterine Fibroid Risk
by: Marina Ponomarenko, et al.
Published: (2025-07-01)

Unraveling the Association of Liver Steatosis and Fibrosis with Vitamin B12: A Cross-Sectional Study
by: Silvia Espina, et al.
Published: (2024-11-01)

Clopidogrel ameliorates high-fat diet-induced hepatic steatosis in mice through activation of the AMPK signaling pathway and beyond
by: Ting Tai, et al.
Published: (2024-10-01)

Mendelian randomization study reveals the causal effect of sex hormone binding globulin on osteoporosis
by: Guo-Si-Lang Zuo, et al.
Published: (2025-07-01)

MAFLD - a new approach to fatty liver disease
by: Borys Łozowski, et al.
Published: (2025-05-01)

Prevalence and influencing factors of MAFLD among residents aged 65 years and older in a district of Wuhan
by: Wen-Shuang WEI, et al.
Published: (2022-04-01)

MASLD vs. MAFLD. A narrative review
by: Amedeo Lonardo, et al.
Published: (2025-08-01)

Hepatoprotective and Fat-Accumulation-Reductive Effects of Curcumin on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
by: Jasmine Harumi Sabini, et al.
Published: (2025-02-01)

An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis
by: M. Imawari, et al.
Published: (2023-11-01)

Profile of Children With Non-alcoholic Fatty Liver Disease Referred to a Hospital in Iran
by: Amin Ghanbari, et al.
Published: (2024-12-01)

Causal Relationship Between Sex Hormone Binding Globulin and Obstetrical Disorders: A Two-Sample Bidirectional Mendelian Randomization Study
by: Gan Y, et al.
Published: (2025-07-01)

Nonlinear association of sex hormone-binding globulin levels and chronic kidney disease, an analysis based on the National Health and Nutrition Examination Survey (NHANES) 2013–2016
by: Qi Zhang, et al.
Published: (2024-12-01)

Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01)

Review of roles of RNA-binding proteins on NAFLD and the related pharmaceutical measures
by: Changjin Li, et al.
Published: (2025-05-01)

Association of the p.I148m polymorphism in the <i>PNPLA3</i> gene with the severity of nonalcoholic fatty liver disease in various clinical groups
by: D. V. Sidorenko, et al.
Published: (2024-04-01)

Risk factors of metabolic dysfunction-associated fatty liver disease in Chinese nurses: an ambispective cohort study
by: Jing Wang, et al.
Published: (2025-08-01)

The Role of Probiotic in Reducing Hepatic Inflammation Among NAFLD Patients: an Evidence-Based Case Report
by: Alvin Nursalim, et al.
Published: (2017-02-01)

The Role of Probiotic in Reducing Hepatic Inflammation Among NAFLD Patients: an Evidence-Based Case Report
by: Alvin Nursalim, et al.
Published: (2017-02-01)

Higher levels of plasmatic saturated fatty acid were significantly associated with liver fibrosis in HIV mono-infection: A case-control study
by: Cristiane Fonseca de Almeida, et al.
Published: (2024-12-01)